American Chamber of Commerce to the European Union
Trade and business associations · Belgium
In these lists: Biggest budgets, Most meetings, Medicines
- Declared lobbying cost
- €1,500,000 – €1,749,999 Financial year 01/2025-12/2025
- Commission meetings
- 47
- Full-time staff on EU lobbying
- 10.2
- European Parliament access passes
- 16
- Registered since
- 14 Oct 2008
Public records onlyWhat this means
Every profile, record and figure comes from documents published by EU institutions, national authorities, courts, ethics bodies, the EU Transparency Register or established news outlets. We use no leaks, private data or anonymous tips. AI helps us gather and cross-check sources but never decides anyone's guilt: each record keeps its exact legal status and links to its source, so you can check it yourself
Fields of interest
Agriculture and rural development, Banking and financial services, Borders and security, Budget, Business and industry, Climate action, Competition, Consumers, Culture and media, Customs, Digital economy and society, Economy, finance and the euro, Education and training, Employment and social affairs, Energy, Enlargement, Environment, External relations, Food safety, Foreign affairs and security policy, Fraud prevention, Institutional affairs, International co-operation and development, Justice and fundamental rights, Public health, Research and innovation, Single market, Taxation, Trade, Trans-European Networks, Transport, Youth
Medicines and food topics they name
Critical medicines
EU laws and policies they declare following15
- Council Regulation (EC) No 139/2004 on the control of concentrations between undertakings (EU Merger Regulation)
- Directive 2003/87/EC establishing a system for greenhouse gas emission allowance trading within the Union (EU ETS)
- Directive 2009/81/EC on the coordination of procedures for the award of certain works contracts, supply contracts and service contracts in the fields of defence and security
- Regulation (EU) 2017/745 on medical devices (MDR)
- Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR)
- Directive (EU) 2017/828 amending Directive 2007/36/EC as regards the encouragement of long‐term shareholder engagement (SRD II)
- Directive (EU) 2019/633 on unfair trading practices in business‐to‐business relationships in the agricultural and food supply chain
- Regulation (EU) 2019/452 establishing a framework for the screening of foreign direct investments into the Union
- Regulation (EU) 2019/881 on ENISA and on information and communications technology cybersecurity certification (Cybersecurity Act)
- Regulation (EU) 2019/2088 on sustainability‐related disclosures in the financial services sector (SFDR)
- Directive (EU) 2022/2464 as regards corporate sustainability reporting (CSRD)
- Directive (EU) 2022/2523 ensuring a global minimum level of taxation for multinational enterprise groups (Pillar Two)
- Regulation (EU) 2022/2554 on digital operational resilience for the financial sector (DORA)
- Regulation (EU) 2022/2560 on foreign subsidies distorting the internal market
- Regulation (EU) 2023/956 establishing a carbon border adjustment mechanism (CBAM)
Meetings with the Commission
Meetings with Commissioners or their Cabinets since 1 December 2024, as the Commission publishes them